Leptomeningeal Metastases

22 clinical trials · Condition

Record	Firm	Date
Intrathecal Pemetrexed for Leptomeningeal Metastasis (NCT05289908)	The First Hospital of Jilin University	2022-02-21
Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors (NCT04343573)	Memorial Sloan Kettering Cancer Center	2020-04-10
Avelumab With Radiotherapy in Patients With Leptomeningeal Disease (NCT03719768)	H. Lee Moffitt Cancer Center and Research Institute	2019-06-10
BATs in Patients With Breast Cancer and Leptomeningeal Metastases (NCT03661424)	University of Virginia	2019-02-26
131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases (NCT03275402)	Y-mAbs Therapeutics	2018-12-11
Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases (NCT03520504)	Memorial Sloan Kettering Cancer Center	2018-04-26
Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer (NCT03101579)	The First Hospital of Jilin University	2017-03-01
Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases (NCT02616393)	Kadmon Corporation, LLC	2015-11-01
Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease (NCT01438021)	City of Hope Medical Center	2012-09-01
Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast Cancer (NCT01645839)	Centre Oscar Lambret	2011-08-30
Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer (NCT00992602)	University of Washington	2011-04-01
Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment (NCT00005811)	National Cancer Institute (NCI)	2000-04-01

Track Leptomeningeal Metastases automatically

Every clearance here is in the API, with alerts when new ones post.